TLSA Tiziana Life Sciences Ltd
Company Analysis
Latest News
Tiziana Life Sciences Ltd Q1 2026 Earnings Preview: What Analysts Expect on August 07, 2026
Analysts expect Tiziana Life Sciences to report zero revenue and a consensus EPS loss of $0.03, with the current stock price of $1.03 trading significantly...
🟢 Tiziana Life Sciences is trading 5.1% up today on technical rebound and biotech strength
Tiziana Life Sciences is trading 5.1% up at $1.04 in after-hours trading, extending a recent recovery driven by a technical rebound and broader strength across...
🟢 Tiziana Life Sciences is trading 6.4% up today after a technical rebound and broader biotech strength
Tiziana Life Sciences is trading at $1.03 (+6.38%) after a technical rebound from recent volatility and broader strength in the biotech sector. • The move...
🟢 Tiziana Life Sciences is trading 5.2% up today in a technical recovery after recent volatility
Tiziana Life Sciences is trading 5.2% up at $1.02, rebounding after an 11.5% decline on August 3 that occurred without a clear news catalyst. • The move...
🟢 Tiziana Life Sciences is trading 5.2% up today, rebounding after recent volatility
Tiziana Life Sciences is trading at $1.02 (5.2%) up today, rebounding from a sharp 11.5% decline on August 3 as the market corrects for recent volatility. •...
🔴 Tiziana Life Sciences is trading 11.5% down today on sharp volatility without a clear news catalyst
Tiziana Life Sciences is trading 11.5% down today at $0.91 amid sharp, stock-specific volatility despite a lack of clear news catalysts. • The decline...
🔴 Tiziana Life Sciences is trading 6.6% down today on stock-specific volatility
Tiziana Life Sciences is trading at $0.96 (-6.59%) on stock-specific volatility, as no direct company news or catalysts have been identified for the move. •...
🟢 Tiziana Life Sciences Ltd is trading 4.37% up
TLSA is trading at $1.07, up 4.37%.
🟢 Tiziana Life Sciences is trading 5.8% up today after positive Phase 2 MSA trial data
Tiziana Life Sciences is trading 5.8% up at $1.09 following positive Phase 2 PET imaging results from a Multiple System Atrophy (MSA) patient treated with...
🟢 Tiziana Life Sciences is trading 13% up today after reporting positive Phase 2 PET imaging results for intranasal foralumab in Multiple System Atrophy
Tiziana Life Sciences is trading 13% up at $1.10 today. The surge follows the company's announcement of positive quantitative PET imaging results from the...
🟢 Tiziana Life Sciences is trading 5.1% up today on a technical rebound and dip-buying
Tiziana Life Sciences is trading at $1.02 (+5.15%) in pre-market, extending a technical rebound and dip-buying trend that began in late July. • The move...
🟢 Tiziana Life Sciences is trading 5.3% up today as technical recovery continues
Tiziana Life Sciences is trading 5.3% up today at $0.96 as the stock continues its rebound from the sharp July 24 selloff. • Dip buyers remain active, driving...
🟢 Tiziana Life Sciences is trading 7.5% up today as rebound from July 24 selloff continues
Tiziana Life Sciences is trading at $1.04 (7.5% up) in pre-market, extending its sharp recovery following the significant selloff on July 24. • The upward...
🟢 Tiziana Life Sciences is trading 7.5% up today as it extends its rebound from the July 24 selloff
Tiziana Life Sciences is trading at $1.04 (7.5%) up in after-hours trading, extending its recent recovery following the selloff on July 24. • The upward move...
🟢 Tiziana Life Sciences is trading 5.45% up today, extending a modest rebound despite broader sector weakness
Tiziana Life Sciences is trading at $0.96 (+5.45%) as of the July 28 session, extending a modest rebound from the prior day’s gains despite a lack of fresh...
🟢 Tiziana Life Sciences is trading 5.3% up today on broader biotech sector strength and a modest rebound
Tiziana Life Sciences is trading 5.3% up today at $0.94, rebounding from a sharp decline on Friday that followed an earlier insider-buying rally. • The upward...
Tiziana's Chairman Owns a Third of the Company — But Can Insider Conviction Alone Carry a Sub-Dollar Stock?
Shares of Tiziana Life Sciences (TLSA) slid 10.5% to $0.91 on July 24, giving back gains from a rally triggered when the company's founder disclosed fresh...
🔴 Tiziana Life Sciences is trading 10.5% down today as it pulls back from a recent insider-buying rally
Tiziana Life Sciences is trading 10.5% down at $0.91, giving back a portion of its recent gains fueled by insider activity. • The stock is pulling back after...
🔴 Tiziana Life Sciences is trading 6.9% down today in a pullback after its insider-buying rally
Tiziana Life Sciences is trading 6.9% down at $0.95 today, appearing to pull back after a sharp rally sparked by insider buying disclosures. • The recent move...
🟢 Tiziana Life Sciences is trading 6% up today after Chairman Gabriele Cerrone increased his stake
Tiziana Life Sciences is trading at $1.00 (+5.94%) following a disclosed insider purchase by Chairman Gabriele Cerrone. • Cerrone acquired 42,357 additional...